Načítá se...
Adalimumab: a Treatment Option for Pyoderma Gangrenosum After Failure of Systemic Standard Therapies
BACKGROUND: Pyoderma gangrenosum (PG) belongs to a group of neutrophilic dermatoses and is often associated with systemic disorders. The authors present a patient with a recalcitrant PG that did not respond to systemic standard therapies, and discuss further treatment options with impact on quality...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Healthcare Communications
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3510423/ https://ncbi.nlm.nih.gov/pubmed/23205329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-012-0006-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|